Tag - medicine-4

 
 

MEDICINE 4

Japan Times
ASIA PACIFIC
Jun 11, 2021
Indians still battling impacts of COVID-19 now burdened with medical debt
Even before the pandemic struck, India's out-of-pocket expenses on health care were among the highest in the world.
Japan Times
COMMENTARY / World
Jun 10, 2021
Fixing the broken pandemic financing system
The devastation caused by COVID-19 has underscored what experts have said for years: our national, regional and global systems are grossly inadequate for detecting and containing outbreaks.
Japan Times
WORLD
Jun 9, 2021
Biggest vaccine-maker’s problems keep world short of COVID-19 shots
The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.
Japan Times
JAPAN / Science & Health
Jun 8, 2021
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
Japan Times
COMMENTARY / World
Jun 7, 2021
The world should learn from India’s COVID-19 cataclysm
Strategies that kept the pandemic at bay in 2020 won't necessarily work in 2021.
Japan Times
COMMENTARY / World
Jun 6, 2021
Lessons from the pandemic
Most countries are lagging far behind and new, concerted and more generous efforts by the richest nations are needed to control the pandemic at a global level.
Japan Times
JAPAN / FOCUS
Jun 4, 2021
In Japan, the light at the end of the pandemic's tunnel remains distant
The vaccine rollout may be accelerating, but the nation remains far away from a return to normalcy.
Japan Times
BUSINESS / FOCUS
Jun 4, 2021
Chinese drugmakers take aim at lucrative U.S. anti-cancer market
In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.
Japan Times
WORLD / Science & Health
May 28, 2021
AstraZeneca clot research continues amid German theory
German researchers said this week they discovered a link between the vaccine and rare blood clots.
Japan Times
WORLD / Science & Health
May 27, 2021
Immunity to the coronavirus may persist for years, scientists find
The findings may help put to rest lingering fears that protection against the virus will be short-lived.
Japan Times
COMMENTARY / World
May 26, 2021
Our responsibility to South Asia
Beyond inflicting agony on the sick, the coronavirus outbreak in the world's most populous democracy is now robbing victims of their dignity in death, too.
Japan Times
COMMENTARY / World
May 26, 2021
Sexy tea, the 'Lion King' and Taiwan's lost innocence
In just one week earlier this month, the case count for COVID-19 infections in Taiwan spiked by more than 40%, and it's likely that figure will keep climbing.
Japan Times
COMMENTARY / World
May 24, 2021
Asia’s COVID-19 surges should worry us all
Variants must be caught before they explode, and we can't afford to overlook what's happening now across the region.
Japan Times
JAPAN / Science & Health
May 23, 2021
Japan clinical trial of COVID-19 plasma therapy highlights slow-moving medical policy
Doctors are gearing up for clinical trials of convalescent plasma therapy, but many overseas hospitals have already moved on to other remedies.
Japan Times
WORLD
May 21, 2021
Delaying second doses offers wider immunity where vaccines are scarce
The initially controversial strategy has now been vindicated by scientific studies, allowing supplies to be more widely distributed and boosting their protective power.
Japan Times
WORLD / Science & Health
May 21, 2021
The latest coronavirus comes from dogs
Scientists have discovered a new canine coronavirus in a child who was hospitalized with pneumonia in Malaysia in 2018. If the virus is confirmed to be a human pathogen, it would be the eighth coronavirus, and the first canine coronavirus, known to cause disease in humans.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?